Sutro Biopharma to Participate in Two Virtual Investor Conferences in June prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies.
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021 forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
DNAtrix to Present at the Raymond James Human Health Innovations Conference News provided by Share this article Share this article HOUSTON, June 9, 2021 /PRNewswire/ DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced that the company will present at the Raymond James Human Health Innovations Conference on Monday, June 21, 2021, at 1:20 pm ET. A live webcast of the presentation is available for access in the Newsroom section of DNAtrix s website at https://www.dnatrix.com/newsroom/. An archived replay of the presentation will be available for 30 days following the day of the event. About DNAtrix DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based on an engineered version of the common cold virus that is designed to selectively infect and kill cancer cells while leaving healthy cells unharmed. The company s lead product candidate is DNX-2401, which will enter into a global pivotal Phase 3 clinical study for patients with recurrent glioblastoma. DNX-2401 is also being evaluated in a Phase 1 study for diffuse intrinsic pontine glioma, for which it has received FDA Fast Track and Rare Pediatric Disease designations. A second product candidate, DNX-2440, is in Phase 1 clinical testing in patients with colorectal and other cancers with liver metastasis. The company s investors include Morningside Ventures and Mercury Fund. For more information, please visit the company website at www.DNAtrix.com.
Aytu BioPharma, Inc.: Aytu BioPharma to Present at Upcoming June Investor Conferences ENGLEWOOD, CO / ACCESSWIRE / May 25, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that Josh Disbrow, Chairman and Chief Executive Officer, will present at two upcoming investor conferences in June: Jefferies Global Healthcare Conference: A live virtual presentation will occur on Tuesday, June 1, 2021 at 3:30 p.m. ET. Webcast Link: https://wsw.com/webcast/jeff174/aytu/1881765 Raymond James Human Health Innovations Conference: A live virtual presentation will occur on Wednesday, June 23, 2021 at 12:40 p.m. ET. These presentations will be available on the conference websites and the Investors section of Aytu Bioscience s website at
Aytu BioPharma to Present at Upcoming June Investor Conferences newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Aytu BioPharma to Present at Upcoming June Investor Conferences pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Aytu BioPharma to Present at Upcoming June Investor Conferences saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Poxel SA: Poxel Announces Participation at Upcoming Virtual Investor Conferences in June POXEL SA (Euronext POXEL FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced its participation at upcoming virtual investor conferences in June 2021. Thomas Kuhn, CEO, will present the company and Poxel management team members will be available for one-on-one virtual meetings. Jefferies Global Healthcare Conference st from 11:00 am to 11:25 am ET. JMP Securities Conference th from 10:30 am to 10:55 am ET. Raymond James Human Health Innovations Conference Date: June 21-23 nd from 8:40 am to 9:10 am ET.
Poxel Announces Participation at Upcoming Virtual Investor Conferences in June streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.